|
Volumn 7, Issue 4, 2006, Pages
|
Cancer and kinases: Reports from the front line
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7 HYDROXYSTAUROSPORINE;
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
B RAF KINASE;
BCR ABL PROTEIN;
CHIR 265;
CHIR 285;
CYTARABINE;
CYTOTOXIC AGENT;
DASATINIB;
DAUNORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
ETOPOSIDE;
FLT3 LIGAND;
GEFITINIB;
HEAT SHOCK PROTEIN 90 INHIBITOR;
IMATINIB;
IRINOTECAN;
JANUS KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
MITOXANTRONE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE INHIBITOR;
STAUROSPORINE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
XL 418;
PROTEIN TYROSINE KINASE;
ACUTE GRANULOCYTIC LEUKEMIA;
ANTIBODY AFFINITY;
ANTINEOPLASTIC ACTIVITY;
BIOLUMINESCENCE;
CANCER CHEMOTHERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG POTENTIATION;
DRUG RESPONSE;
DRUG SCREENING;
DRUG TARGETING;
ENZYME ASSAY;
ENZYME INHIBITION;
EXPERIMENTAL NEOPLASM;
HEMATOLOGIC MALIGNANCY;
HUMAN;
LUNG CANCER;
MASS SPECTROMETRY;
MUTATIONAL ANALYSIS;
MYELOPROLIFERATIVE DISORDER;
NONHUMAN;
POSITRON EMISSION TOMOGRAPHY;
PROTEOMICS;
RNA INTERFERENCE;
SIGNAL TRANSDUCTION;
SOLID TUMOR;
DRUG ANTAGONISM;
DRUG RESISTANCE;
FLOW CYTOMETRY;
NEOPLASM;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
FLOW CYTOMETRY;
HUMANS;
NEOPLASMS;
POSITRON-EMISSION TOMOGRAPHY;
PROTEIN KINASE INHIBITORS;
RECEPTOR PROTEIN-TYROSINE KINASES;
|
EID: 33748413525
PISSN: 1474760X
EISSN: 1474760X
Source Type: Journal
DOI: 10.1186/gb-2006-7-4-314 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|